Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs

Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study

(2010) Mélanie Gilson et al.   ARTHRITIS RESEARCH & THERAPY

Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-  blockers: perioperative interruption of tumour necrosis factor-  blockers decreases complications?

(2009) K. Kawakami et al.   RHEUMATOLOGY

Orthopaedic surgery in 255 patients with inflammatory arthropathies: longitudinal effects on pain, physical function and health-related quality of life

(2008) H Osnes-Ringen et al.   ANNALS OF THE RHEUMATIC DISEASES

Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab

(2008) M Hirao et al.   ANNALS OF THE RHEUMATIC DISEASES

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

(2008) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis

(2008) Tim Bongartz et al.   ARTHRITIS AND RHEUMATISM

The place of methotrexate perioperatively in elective orthopedic surgeries in patients with rheumatoid arthritis

(2008) Herwig Pieringer et al.   CLINICAL RHEUMATOLOGY

Surgery Insight: orthopedic treatment options in rheumatoid arthritis

(2008) Beat R Simmen et al.   Nature clinical practice. Rheumatology